Iron Triangle Partners
Latest statistics and disclosures from Iron Triangle Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CRL, ISRG, RGEN, JAZZ, VCYT, and represent 31.18% of Iron Triangle Partners's stock portfolio.
- Added to shares of these 10 stocks: ISRG (+$54M), BSX (+$40M), WAT (+$40M), BRKR (+$37M), VRTX (+$35M), FTRE (+$34M), MMSI (+$34M), TECH (+$28M), ATEC (+$27M), NVST (+$26M).
- Started 16 new stock positions in FTRE, WAT, MLYS, DNTH, VRTX, MMSI, BSX, ISRG, NVST, UNH. ATEC, ABT, TECH, XENE, BHVN, BRKR.
- Reduced shares in these 10 stocks: DXCM (-$57M), , MDT (-$43M), CVS (-$29M), GKOS (-$28M), , , ADPT (-$27M), MDGL (-$27M), GH (-$25M).
- Sold out of its positions in ABBV, ADPT, FOLD, ARGX, CAH, DXCM, EXAS, GKOS, GH, MDGL. NBIX, THC, WST, MDT.
- Iron Triangle Partners was a net buyer of stock by $109M.
- Iron Triangle Partners has $875M in assets under management (AUM), dropping by 24.37%.
- Central Index Key (CIK): 0001779763
Tip: Access up to 7 years of quarterly data
Positions held by Iron Triangle Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Iron Triangle Partners
Iron Triangle Partners holds 27 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Charles River Laboratories (CRL) | 8.7 | $76M | +41% | 380k | 199.48 |
|
| Intuitive Surgical Com New (ISRG) | 6.1 | $54M | NEW | 95k | 566.36 |
|
| Repligen Corporation (RGEN) | 6.0 | $53M | +18% | 321k | 163.86 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.7 | $50M | +94% | 292k | 170.00 |
|
| Veracyte (VCYT) | 4.7 | $41M | +102% | 980k | 42.10 |
|
| Boston Scientific Corporation (BSX) | 4.6 | $40M | NEW | 421k | 95.35 |
|
| Waters Corporation (WAT) | 4.6 | $40M | NEW | 105k | 379.83 |
|
| Brookdale Senior Living (BKD) | 4.3 | $38M | +23% | 3.5M | 10.79 |
|
| Eli Lilly & Co. (LLY) | 4.3 | $38M | -29% | 35k | 1074.68 |
|
| Bruker Corporation (BRKR) | 4.3 | $37M | NEW | 794k | 47.11 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.0 | $35M | NEW | 77k | 453.36 |
|
| CVS Caremark Corporation (CVS) | 3.9 | $34M | -45% | 433k | 79.36 |
|
| Fortrea Hldgs Common Stock (FTRE) | 3.9 | $34M | NEW | 2.0M | 17.25 |
|
| Merit Medical Systems (MMSI) | 3.9 | $34M | NEW | 386k | 88.14 |
|
| Brightspring Health Svcs (BTSG) | 3.8 | $34M | -27% | 897k | 37.45 |
|
| Doximity Cl A (DOCS) | 3.5 | $30M | +226% | 687k | 44.28 |
|
| Bio-techne Corporation (TECH) | 3.1 | $28M | NEW | 467k | 58.81 |
|
| Alphatec Hldgs Com New (ATEC) | 3.1 | $27M | NEW | 1.3M | 21.04 |
|
| Adapthealth Corp Common Stock (AHCO) | 3.0 | $26M | +35% | 2.6M | 9.96 |
|
| Envista Hldgs Corp (NVST) | 2.9 | $26M | NEW | 1.2M | 21.71 |
|
| UnitedHealth (UNH) | 2.6 | $23M | NEW | 70k | 330.11 |
|
| Abbott Laboratories (ABT) | 2.5 | $22M | NEW | 175k | 125.29 |
|
| Ideaya Biosciences (IDYA) | 1.8 | $16M | +73% | 468k | 34.57 |
|
| Biohaven (BHVN) | 1.2 | $11M | NEW | 958k | 11.29 |
|
| Xenon Pharmaceuticals (XENE) | 1.2 | $11M | NEW | 234k | 44.82 |
|
| Dianthus Therapeutics (DNTH) | 1.1 | $9.5M | NEW | 231k | 41.21 |
|
| Mineralys Therapeutics (MLYS) | 1.1 | $9.3M | NEW | 257k | 36.29 |
|
Past Filings by Iron Triangle Partners
SEC 13F filings are viewable for Iron Triangle Partners going back to 2019
- Iron Triangle Partners 2025 Q4 filed Feb. 17, 2026
- Iron Triangle Partners 2025 Q3 filed Nov. 14, 2025
- Iron Triangle Partners 2025 Q2 filed Aug. 14, 2025
- Iron Triangle Partners 2025 Q1 filed May 15, 2025
- Iron Triangle Partners 2024 Q4 filed Feb. 14, 2025
- Iron Triangle Partners 2024 Q3 filed Nov. 14, 2024
- Iron Triangle Partners 2024 Q2 filed Aug. 14, 2024
- Iron Triangle Partners 2024 Q1 filed May 15, 2024
- Iron Triangle Partners 2023 Q4 filed Feb. 14, 2024
- Iron Triangle Partners 2023 Q3 filed Nov. 14, 2023
- Iron Triangle Partners 2023 Q2 filed Aug. 14, 2023
- Iron Triangle Partners 2023 Q1 filed May 15, 2023
- Iron Triangle Partners 2022 Q4 filed Feb. 14, 2023
- Iron Triangle Partners 2022 Q3 filed Nov. 14, 2022
- Iron Triangle Partners 2022 Q2 filed Aug. 15, 2022
- Iron Triangle Partners 2022 Q1 filed May 16, 2022